Future medical and non-medical costs and their impact on the cost-effectiveness of life-prolonging interventions: a comparison of five European countries

European Journal of Health Economics

Aug 4

Written By Matthijs Versteegh

Methods

Matthijs Versteegh

Cost-Effectiveness Analysis of Treating Patients With NTRK-Positive Cancer With the Histology-Independent Therapy Entrectinib

Estimating Quality of Life Decrements in Oncology Using Time to Death